- Report
- September 2024
- 82 Pages
Japan
From €3180EUR$3,500USD£2,734GBP
- Report
- August 2023
- 75 Pages
Israel
From €3180EUR$3,500USD£2,734GBP
- Clinical Trials
- April 2025
- 240 Pages
Global
From €2272EUR$2,500USD£1,953GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1363EUR$1,500USD£1,172GBP
- Drug Pipelines
- December 2022
- 30 Pages
Global
From €2953EUR$3,250USD£2,539GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1363EUR$1,500USD£1,172GBP
- Report
- February 2023
- 220 Pages
Global
From €6815EUR$7,500USD£5,858GBP
- Report
- July 2025
- 350 Pages
Global
From €4497EUR$4,949USD£3,866GBP
- Report
- July 2025
- 350 Pages
Global
From €4497EUR$4,949USD£3,866GBP
- Report
- June 2025
- 200 Pages
Global
From €2534EUR$2,789USD£2,178GBP
- Report
- June 2025
- 200 Pages
Global
From €2534EUR$2,789USD£2,178GBP
- Report
- June 2025
- 400 Pages
Global
From €4497EUR$4,949USD£3,866GBP
- Report
- May 2024
- 130 Pages
Global
From €2725EUR$2,999USD£2,343GBP
€3634EUR$3,999USD£3,124GBP
- Report
- May 2024
- 133 Pages
Global
From €2725EUR$2,999USD£2,343GBP
€3634EUR$3,999USD£3,124GBP
- Report
- June 2026
- 117 Pages
Mexico
From €2725EUR$2,999USD£2,343GBP
€3634EUR$3,999USD£3,124GBP
- Report
- April 2025
- 150 Pages
Global
From €4407EUR$4,850USD£3,788GBP
- Report
- March 2024
- 150 Pages
Global
From €4407EUR$4,850USD£3,788GBP
From €4089EUR$4,500USD£3,515GBP
- Report
- July 2024
- 268 Pages
China
From €3635EUR$4,000USD£3,124GBP
- Report
- July 2024
- 141 Pages
China
From €1636EUR$1,800USD£1,406GBP

The Vasodilator market is a segment of the Medical Devices industry that focuses on the development and sale of products used to widen blood vessels. These products are used to treat a variety of conditions, including hypertension, coronary artery disease, and peripheral vascular disease. Vasodilators are typically administered through injection, infusion, or inhalation, and can be used to reduce blood pressure, improve blood flow, and reduce the risk of stroke and heart attack.
The Vasodilator market is highly competitive, with a number of large and small companies offering a variety of products. Major players in the market include Pfizer, Merck, Novartis, and Sanofi, while smaller companies such as Bausch Health, Mylan, and Teva Pharmaceuticals also offer products. Additionally, many generic drug manufacturers produce generic versions of popular vasodilators. Show Less Read more